164 related articles for article (PubMed ID: 38125301)
1. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality.
Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Dannenberg V; Trauner M; Mandorfer M; Reiberger T
JHEP Rep; 2024 Jan; 6(1):100954. PubMed ID: 38125301
[TBL] [Abstract][Full Text] [Related]
2. An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosis.
Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Trauner M; Mandorfer M; Reiberger T
JHEP Rep; 2023 Aug; 5(8):100789. PubMed ID: 37484210
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
J Hepatol; 2021 Apr; 74(4):819-828. PubMed ID: 33075344
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis.
Simbrunner B; Hartl L; Jachs M; Bauer DJM; Scheiner B; Hofer BS; Stättermayer AF; Marculescu R; Trauner M; Mandorfer M; Reiberger T
JHEP Rep; 2023 May; 5(5):100712. PubMed ID: 37035457
[TBL] [Abstract][Full Text] [Related]
5. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
Balcar L; Krawanja J; Scheiner B; Paternostro R; Simbrunner B; Semmler G; Jachs M; Hartl L; Stättermayer AF; Schwabl P; Pinter M; Szekeres T; Trauner M; Reiberger T; Mandorfer M
JHEP Rep; 2023 Apr; 5(4):100682. PubMed ID: 36873421
[TBL] [Abstract][Full Text] [Related]
6. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M
J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090
[TBL] [Abstract][Full Text] [Related]
7. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.
Paternostro R; Kwanten WJ; Hofer BS; Semmler G; Bagdadi A; Luzko I; Hernández-Gea V; Graupera I; García-Pagán JC; Saltini D; Indulti F; Schepis F; Moga L; Rautou PE; Llop E; Téllez L; Albillos A; Fortea JI; Puente A; Tosetti G; Primignani M; Zipprich A; Vuille-Lessard E; Berzigotti A; Taru MG; Taru V; Procopet B; Jansen C; Praktiknjo M; Gu W; Trebicka J; Ibanez-Samaniego L; Bañares R; Rivera-Esteban J; Pericas JM; Genesca J; Alvarado E; Villanueva C; Larrue H; Bureau C; Laleman W; Ardevol A; Masnou H; Vanwolleghem T; Trauner M; Mandorfer M; Francque S; Reiberger T;
J Hepatol; 2024 May; ():. PubMed ID: 38823501
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease.
Pomej K; Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Bauer D; Pereyra D; Starlinger P; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Reiberger T; Mandorfer M
Dig Liver Dis; 2022 Oct; 54(10):1376-1384. PubMed ID: 35871985
[TBL] [Abstract][Full Text] [Related]
9. Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response.
Simbrunner B; Caparrós E; Neuwirth T; Schwabl P; Königshofer P; Bauer D; Marculescu R; Trauner M; Scheiner B; Stary G; Mandorfer M; Reiberger T; Francés R
Hepatol Int; 2023 Aug; 17(4):1045-1056. PubMed ID: 36881247
[TBL] [Abstract][Full Text] [Related]
10. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
Semmler G; Yang Z; Fritz L; Köck F; Hofer BS; Balcar L; Hartl L; Jachs M; Stopfer K; Schedlbauer A; Neumayer D; Maurer J; Müllner-Bucsics T; Simbrunner B; Scheiner B; Trauner M; Mandorfer M; Reiberger T; Bauer DJM
Gastroenterology; 2023 Oct; 165(4):1041-1052. PubMed ID: 37442301
[TBL] [Abstract][Full Text] [Related]
11. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension.
Raeven P; Baron-Stefaniak J; Simbrunner B; Stadlmann A; Schwabl P; Scheiner B; Schaden E; Eigenbauer E; Quehenberger P; Mandorfer M; Baron DM; Reiberger T
Hepatol Int; 2020 Dec; 14(6):1083-1092. PubMed ID: 33000389
[TBL] [Abstract][Full Text] [Related]
12. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes.
Hartl L; Jachs M; Desbalmes C; Schaufler D; Simbrunner B; Paternostro R; Schwabl P; Bauer DJM; Semmler G; Scheiner B; Bucsics T; Eigenbauer E; Marculescu R; Szekeres T; Peck-Radosavljevic M; Kastl S; Trauner M; Mandorfer M; Reiberger T
Hepatol Int; 2021 Oct; 15(5):1160-1173. PubMed ID: 34021479
[TBL] [Abstract][Full Text] [Related]
13. Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.
Scheiner B; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Bauer D; Simbrunner B; Schmidt R; Marculescu R; Ferlitsch A; Peck-Radosavljevic M; Pinter M; Trauner M; Reiberger T; Ferenci P; Mandorfer M
Liver Int; 2020 Feb; 40(2):393-404. PubMed ID: 31967400
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.
Simbrunner B; Villesen IF; Scheiner B; Paternostro R; Schwabl P; Stättermayer AF; Marculescu R; Pinter M; Quehenberger P; Trauner M; Karsdal M; Lisman T; Reiberger T; Leeming DJ; Mandorfer M
Hepatol Int; 2023 Dec; 17(6):1532-1544. PubMed ID: 37605068
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient ≤ 10 mm Hg.
Jindal A; Sarin SK; Kumar M; Kumar G
Dig Dis Sci; 2022 Nov; 67(11):5280-5289. PubMed ID: 35113276
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.
Dominik N; Scheiner B; Zanetto A; Balcar L; Semmler G; Campello E; Schwarz M; Paternostro R; Simbrunner B; Hofer BS; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Simioni P; Reiberger T; Mandorfer M
Aliment Pharmacol Ther; 2024 Jun; 59(11):1376-1386. PubMed ID: 38482706
[TBL] [Abstract][Full Text] [Related]
17. Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis.
Hofer BS; Simbrunner B; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Semmler G; Hartl L; Jachs M; Datterl B; Staettermayer AF; Trauner M; Mandorfer M; Reiberger T
Hepatol Commun; 2022 Sep; 6(9):2569-2580. PubMed ID: 35808889
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.
Simbrunner B; Semmler G; Stadlmann A; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Bauer D; Eigenbauer E; Pinter M; Stättermayer AF; Quehenberger P; Marculescu R; Trauner M; Mandorfer M; Reiberger T
Hepatol Int; 2020 Dec; 14(6):1093-1103. PubMed ID: 33289910
[TBL] [Abstract][Full Text] [Related]
19. Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests?
Dajti E; Alemanni LV; Marasco G; Montagnani M; Azzaroli F
Hepat Med; 2021; 13():25-36. PubMed ID: 33776492
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
Bastati N; Beer L; Ba-Ssalamah A; Poetter-Lang S; Ambros R; Kristic A; Lauber D; Pomej K; Binter T; Simbrunner B; Semmler G; Balcar L; Bican Y; Hodge JC; Wrba T; Trauner M; Reiberger T; Mandorfer M
J Hepatol; 2022 Oct; 77(4):1005-1013. PubMed ID: 35525337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]